Amgen's (AMGN) Tavneos main study said to have been retracted from New England Journal of Medicine
#AMGEN INC#AMGN.US#EQUITIES#US SESSION#BIOTECHNOLOGY#BIOTECHNOLOGY (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#NASDAQ 100 INDEX#AMGN#US EQUITIES